Jong Hwa Jung

Title: Innovations of Jong Hwa Jung

Introduction

Jong Hwa Jung is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of various health disorders. With a total of two patents to his name, his work reflects a commitment to advancing medical science.

Latest Patents

Jong Hwa Jung's latest patents include a pharmaceutical composition for the prevention or treatment of circadian rhythm-related disorders. This composition comprises an oxyiminomethylbenzene derivative as the active ingredient. The second patent focuses on a novel N-acylurea derivative and its use for the prevention or treatment of cardiovascular disease. This invention highlights the ability of the N-acylurea derivative to inhibit platelet aggregation by targeting the activity of talin in the intracellular matrix.

Career Highlights

Throughout his career, Jong Hwa Jung has been associated with prominent research institutions. He has worked with the Korea University Research and Business Foundation and the Kyungpook National University Industry-Academic Cooperation Foundation. His contributions in these roles have furthered research and development in the pharmaceutical sector.

Collaborations

Jong Hwa Jung has collaborated with notable colleagues, including Gi Hoon Son and Soon Jun Hong. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

Jong Hwa Jung's innovative work in pharmaceuticals demonstrates his dedication to improving health outcomes through scientific research. His patents reflect a significant contribution to the medical field, particularly in addressing circadian rhythm-related disorders and cardiovascular diseases.